22nd Century Group, Inc. (XXII)
$
1.3
-0.21 (-16.15%)
Key metrics
Financial statements
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
22nd Century Group, Inc., an agricultural biotechnology firm established in 1998 and based in Buffalo, New York, specializes in tobacco harm reduction, low nicotine tobacco products, and advancements in health and wellness through plant science. The company reported an income before tax of -$15,465,000.00 showcasing its pre-tax profitability. The gross profit ratio is -0.20 reflecting the efficiency of the company's production and sales operations. Additionally, the company recorded an operating income of -$13,950,000.00 which highlights its earnings from core operations while also incurring an interest expense of $2,094,000.00 reflecting its debt servicing obligations. The earnings per share (EPS) is reported at -$0.10 indicating the company's profitability on a per-share basis. To further its mission, 22nd Century Group develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes intended for use in independent clinical studies. Collaborating with Keygene N.V., the company is also focused on developing hemp and cannabis plants that exhibit exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, agricultural, and various applications. Currently, the stock is affordable at $1.43 making it suitable for budget-conscious investors. However, the stock has a low average trading volume of 934,136.00 indicating lower market activity. With a market capitalization of $3,080,415.00 the company is classified as a small-cap player, positioning itself as a key contributor in the Tobacco industry that significantly impacts the overall market landscape. Moreover, it belongs to the Consumer Defensive sector, driving innovation and growth within its domain. Through these strategic initiatives and market positioning, 22nd Century Group, Inc. continues to play a vital role in the advancement of agricultural biotechnology and tobacco harm reduction.
Is 22nd Century Group, Inc. (XXII) a good investment?
Investing in 22nd Century Group, Inc. (XXII) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bullish outlook. Always conduct your own research before investing.
What is 22nd Century Group, Inc. (XXII)'s stock forecast?
Analysts predict 22nd Century Group, Inc. stock to fluctuate between $1.24 (low) and $581.85 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is 22nd Century Group, Inc.'s market capitalization?
As of 2025-04-03, 22nd Century Group, Inc.'s market cap is $3,080,415, based on 2,369,550 outstanding shares.
How does 22nd Century Group, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., 22nd Century Group, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy 22nd Century Group, Inc. (XXII) stock?
To buy 22nd Century Group, Inc. (XXII) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for XXII. Place an order (Market, Limit, etc.).
What is the best time to invest in 22nd Century Group, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has 22nd Century Group, Inc. stock ever split?
22nd Century Group, Inc.'s last stock split was 1:135 on 2024-12-17.
How did 22nd Century Group, Inc. perform in the last earnings report?
Revenue: $11,878,000 | EPS: -$0.10 | Growth: -99.91%.
Where can I find 22nd Century Group, Inc.'s investor relations reports?
Visit https://www.xxiicentury.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for 22nd Century Group, Inc.?
You can explore historical data from here
What is the all-time high and low for 22nd Century Group, Inc. stock?
All-time high: $196,668 (2021-04-26) | All-time low: $1.11 (2025-04-03).
What are the key trends affecting 22nd Century Group, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
14 days ago
22nd Century Group, Inc. (NASDAQ:XXII ) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's Fourth Quarter and Full Year 2024 Conference Call and Webcast. At this time, all participants are -- have been placed in a listen-only mode.
globenewswire.com
14 days ago
Launches 2025 Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Announces First VLN ® Partner Brands with Smoker Friendly Ready for Shipment in Q2 2025, Additional Partner VLN ® Brands in Discussion MOCKSVILLE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the fourth quarter and year-ended December 31, 2024, and provided an update on recent business highlights.
globenewswire.com
20 days ago
MOCKSVILLE, N.C., March 14, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, will host a webcast on Thursday, March 20, 2025, at 8:00 AM ET to discuss its 2024 fourth quarter and full year results, which are to be reported in a press release at 6:00 AM ET the same day.
globenewswire.com
24 days ago
Smoker Friendly Adds Both VLN and Smoker Friendly Branded VLN Reduced Nicotine Content Products to its Store Lineup MOCKSVILLE, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced that it has signed an agreement with Smoker Friendly, one of its largest customers, to launch Smoker Friendly VLN branded reduced nicotine content cigarette products that will become the first VLN partner brand.
newsfilecorp.com
2 months ago
Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed.
globenewswire.com
2 months ago
MOCKSVILLE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present at the Emerging Growth Conference on Wednesday, February 19, 2025, at 10:50 am Eastern Time.
globenewswire.com
2 months ago
MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2).
globenewswire.com
3 months ago
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
globenewswire.com
3 months ago
VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA's War on Smoking
globenewswire.com
3 months ago
FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food and Drug Administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the U.S. Office of Management and Budget on January 3, 2025.
See all news
